Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?
- 15 December 2020
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 34 (4) , 834-841
Abstract
No abstract availableKeywords
Funding Information
- Orchid, fighting male cancer Barts and the London Charity
This publication has 39 references indexed in Scilit:
- Predictors of Outcome in Patients with Advanced Nonseminomatous Germ Cell Testicular TumorsAsian Pacific Journal of Cancer Prevention, 2014
- Prediction of metastatic status in non-seminomatous testicular cancerWorld Journal of Urology, 2013
- Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumorsLaboratory Investigation, 2013
- Outcomes of Surveillance Protocol of Clinical Stage I Nonseminomatous Germ Cell Tumors—Is Shift to Risk Adapted Policy Justified?Journal of Urology, 2006
- The continued value of central histopathological review of testicular tumoursHistopathology, 2005
- Predictors of Occult Metastasis in Clinical Stage I Nonseminoma: A Systematic ReviewJournal of Clinical Oncology, 2003
- Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group TrialJournal of Clinical Oncology, 2003
- SURVEILLANCE CAN BE THE STANDARD OF CARE FOR STAGE I NONSEMINOMATOUS TESTICULAR TUMORS AND EVEN HIGH RISK PATIENTSJournal of Urology, 2001
- Stage I non-seminomatous germ-cell tumours of the testisEuropean Journal of Cancer, 2001
- Histopathological features in stage I non‐seminomatous testicular germ cell tumours correlated to relapseAPMIS, 1990